TY - JOUR
T1 - Molecular pathology of high-grade prostatic intraepithelial neoplasia
T2 - Challenges and opportunities
AU - Trabzonlu, Levent
AU - Kulac, Ibrahim
AU - Zheng, Qizhi
AU - Hicks, Jessica L.
AU - Haffner, Michael C.
AU - Nelson, William G.
AU - Sfanos, Karen S.
AU - Ertunc, Onur
AU - Lotan, Tamara L.
AU - Heaphy, Christopher M.
AU - Meeker, Alan K.
AU - Yegnasubramanian, Srinivasan
AU - De Marzo, Angelo M.
N1 - Funding Information:
This work was supported by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins’s Cancer Center Support Grant (National Institutes of Health/National Cancer Center [NIH/ NCI] grant P30 CA006973), the NIH/NCI SPORE in Prostate Cancer P50 CA058236, the NIH/NCI U01 CA196390, and The Patrick C. Walsh Prostate Cancer Research Fund.
Publisher Copyright:
© 2019 Cold Spring Harbor Laboratory Press; all rights reserved.
PY - 2019/4
Y1 - 2019/4
N2 - A better understanding of the early stages of prostate cancer initiation, potentially arising from precursor lesions, may fuel development of powerful approaches for prostate cancer prevention or interception. The best-known candidate for such a precursor lesion has been referred to as high-grade prostatic intraepithelial neoplasia (HGPIN). Although there is significant evidence supporting the notion that such HGPIN lesions can give rise to invasive adenocarcinomas of the prostate, there are also numerous complicating considerations and evidence that cloud the picture in many instances. Notably, recent evidence has suggested that some fraction of such lesions that are morphologically consistent with HGPIN may actually be invasive carcinomas masquerading as HGPIN—a state that we term “postinvasive intraepithelial carcinoma” (PIC). Although the prevalence of such PIC lesions is not fully understood, this and other factors can confound the potential of identifying prostate precursors that can be targeted for disease prevention, interception, or treatment. Here, we review our current understanding of the morphological and molecular pathological features of prostate cancer precursor lesions.
AB - A better understanding of the early stages of prostate cancer initiation, potentially arising from precursor lesions, may fuel development of powerful approaches for prostate cancer prevention or interception. The best-known candidate for such a precursor lesion has been referred to as high-grade prostatic intraepithelial neoplasia (HGPIN). Although there is significant evidence supporting the notion that such HGPIN lesions can give rise to invasive adenocarcinomas of the prostate, there are also numerous complicating considerations and evidence that cloud the picture in many instances. Notably, recent evidence has suggested that some fraction of such lesions that are morphologically consistent with HGPIN may actually be invasive carcinomas masquerading as HGPIN—a state that we term “postinvasive intraepithelial carcinoma” (PIC). Although the prevalence of such PIC lesions is not fully understood, this and other factors can confound the potential of identifying prostate precursors that can be targeted for disease prevention, interception, or treatment. Here, we review our current understanding of the morphological and molecular pathological features of prostate cancer precursor lesions.
UR - http://www.scopus.com/inward/record.url?scp=85064214048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064214048&partnerID=8YFLogxK
U2 - 10.1101/cshperspect.a030403
DO - 10.1101/cshperspect.a030403
M3 - Article
C2 - 30082453
AN - SCOPUS:85064214048
SN - 2157-1422
VL - 9
JO - Cold Spring Harbor Perspectives in Medicine
JF - Cold Spring Harbor Perspectives in Medicine
IS - 4
M1 - a030403
ER -